Ha is Director of the Thang Long Institute of Mathematics and Applied Sciences; professor and former director of the Institute of Mathematics (Vietnam Academy of Science and Technology), member of the State Council for Professor promotion of Vietnam, Chairman of the Council for Professor promotion in Mathematics. His main area of research is analysis and number theory. He has found a generalization of Nevanlinna theory for p-adic functions, and has also found an interpolation theorem for unbounded p-adic analytic functions, also applicable to p-adic L-functions. He is a member of the Vietnamese Academy of Science and Technology.

Su obtained his MS in mechanical engineering from Virginia Polytechnic Institute in 1961 and his PhD in mechanical engineering from UC Berkeley in 1967. He is professor at the State Key Lab of Satellite Ocean Environment Dynamics, Second Institute of Oceanography, State Oceanic Administration, China; honorary director of the Second Institute of Oceanography. He is a member of the Chinese Academy of Sciences since 1992 and foreign member of the Russian Academy of Natural Sciences since 1999. He was Vice-Chairman of the Standing Committee of the Earth Sciences Division of the Chinese Academy of Sciences, 1992-1998 and 2002-2006; Chairman of the Intergovernmental Oceanographic Commission (IOC), 1999-2003; Principal Lead Author (1993-1996) and Convening Lead Author (1996-1997) of IPCC Second Assessment Report / Working Group II, Review Editor (1998-2000) of IPCC Third Assessment Report / Working Group II.

Chen (PhD, 1989, Saint-Louis Hospital, U. of Paris VII) is Vice Chairman, Standing Committee, Natl. People's Congress, China; hon. director, Shanghai Inst. of Hematology, Rui-Jin Hospital, and director, Shanghai Ctr. for Systems Biomedicine, SJTU. His honours include: HLHL Award for Sci. and Technol.; Prix de l'Oise, La Ligue Nationale contre le Cancer; Qiu-Shi Award for Outstanding Young Scientist; Prix Inserm Etranger; Officier, Ordre de la Légion d’honneur, France; 7th Annual Szent-Györgyi Prize for Progress in Cancer Research, Natl. Foundn. for Cancer Research, USA. He is a member of the Chin. Acad. of Scs.; for. assoc., Natl. Acad. of Sciences, US Inst. of Medicine, French Acad. of Sciences and Academia Europaea; ext. scientific member, Max-Planck Soc., Germany; and hon. fellow, UK Acad. of Med. Sciences.

Chen is professor, Shanghai Jiao Tong U. School of Medicine; director, State Key Laboratory of Medical Genomics;director, Shanghai Institute of Hematology, and director, National Research Center for Translational Medicine (Shanghai). She also holds the position of vice-chairman of the Chinese Medical Association. She graduated from Shanghai Second Medical University (presently Shanghai Jiao Tong University School of Medicine) as a bachelor in 1975, got her Master's degree in medicine in 1981 and DSc in 1989 at Paris VII University of France. Her study is focused on leukemia cytogenetics and molecular genetics. She has published more than 300 papers in high level peer reviewed international journals with over 21000 citations. Her awards include: Second Prize of National Natural Science Award by State Council of China; Top Ten Women Elites of China. Her membership includes: Chinese Academy of Engineering and French Academy of Medical Sciences.

Heong is Qiushi Chair professor Zhejiang University and Sr. Advisor, Center for Agricultural Biosciences Internatl. (CABI), Malaysia . He obtained his BSc (zoology) from U. of Malaya; his MSc, PhD and DSc from Imperial College, London. He is recognized internationally as an authority on science, technology and the implementation of pest ecology, biodiversity, ecological engineering, farmers' decision-making and pest management. He has served as a snr. res. off., Malaysian Agric. Res & Development Inst, and principal scientist, International Rice Research Institute (IRRI), Philippines. His honors include: Medal for Agriculture Development, Medal for Scientific Excellence from the Govt. of Vietnam; St Andrews Prize, US Council of Agric S and T Charles Black Award, TWAS Prize for agriculture, WB Marketplace Award, COM+Award for communication, Intern Plant Protection Award of Distinction and Zhejiang Westlake Friendship Award, Research Star Award. He is fellow of Academy of Science, Malaysia.

Dr. Hu is currently Chair Professor of Mechanics with Beijing Institute of Technology, and Presidium Member of Chinese Academy of Sciences. He used to be President of Beijing Institute of Technology (2007-2017), President of Nanjing University of Aeronautics of Aeronautics (2001-2007), Professor of Mechanics with that university (1994-2007), and Humboldt Research Fellow with University of Stuttgart (1992-94). He has made recognized contributions to the nonlinear dynamics of vibration control systems, dynamics of carbon nano-systems, active flutter suppression of aircraft structures, and deployment dynamics of large space structures. He received State Award of Natural Sciences, China twice (2006, 2012), ASME Thomas Caughey Dynamics Medal, USA (2023), and ASCE Raymond Mindlin Medal, USA (2026). He has been Fellow of the Chinese Academy of Sciences (2007), Honorary Doctor of Moscow State University (2015), Honorary Doctor of Science of University of Reading (2016), Honorary Member of Hungary Academy of Sciences (2022), and Foreign Member of Academia Europaea (2026).

Prof. Jian Ding is a renowned Chinese cancer pharmacologist and Academician of the Chinese Academy of Engineering, and he’s made extraordinary contributions to research and development of new drugs. He is currently a researcher at the Shanghai Institute of Materia Medica, and was Director of SIMM(2004-2013). Prof. Ding serves as the editor-in-chief of Acta Pharmacologica Sinica and editorial board member of several international academic journals such as Eur J Pharmacol and Mol Pharmacol. Focusing on biomarkers and drug resistance mechanisms of anti-tumor drugs, Prof. Ding is the co-inventor of more than ten innovative drug candidates, and all of which are currently at clinical trials with one of them has been conditionally approved in China and Japan and 4 of them running additional clinical tests in U.S, Japan & Australia. More than 340 papers have been published in journals including Cell、Cancer Cell etc. Over 150 patents have been authorized. Multiple awards have been bestowed to Prof. Ding to acknowledge his tremendous contribution to the area of cancer treatment, including but not limited to, 2 Second degree of National Natural Science Award.